Currently out of the existing stock ratings of David Li, 3 are a HOLD (100%).

David Li

Work Performance Price Targets & Ratings Chart

Analyst David Li, currently employed carries an average stock price target met ratio of 100% that have a potential upside of 7.65% achieved within 135 days.

David Li’s has documented 6 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BGNE, BeiGene Ltd at 08-Apr-2024.

Wall Street Analyst David Li

Analyst best performing recommendations are on BGNE (BEIGENE LTD).
The best stock recommendation documented was for BGNE (BEIGENE LTD) at 4/12/2023. The price target of $263.3 was fulfilled within 1 day with a profit of $8.42 (3.3%) receiving and performance score of 33.04.

Average potential price target upside

BGNE BeiGene Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$300

$123.5 (69.97%)

$319

20 days ago
(03-Dec-2024)

3/10 (30%)

$93.22 (45.08%)

126

Buy

$260

$83.5 (47.31%)

$254

1 months 10 days ago
(13-Nov-2024)

4/8 (50%)

$61.6 (31.05%)

125

Buy

$288

$111.5 (63.17%)

$285

4 months 15 days ago
(08-Aug-2024)

0/4 (0%)

$104.97 (57.35%)

Hold

$164.3

$-12.2 (-6.91%)

$212

8 months 15 days ago
(08-Apr-2024)

3/3 (100%)

$14.55 (9.72%)

135

Buy

$345

$168.5 (95.47%)

$350

9 months 26 days ago
(27-Feb-2024)

2/5 (40%)

$165.31 (92.00%)

350

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by David Li?

On 2023

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?